
(SeaPRwire) – Blossom Health has secured $20 million in combined seed and Series A financing to introduce an AI “copilot” for psychiatry to patients across the country, has exclusively learned. The news arrives as venture capital has mostly pursued more general AI initiatives, yet investors have been growing more inclined to back AI-powered health technology. The New York City startup is positioning itself as an AI-first psychiatry platform, contending that the technology now enables scaling high-quality mental health care without overstaffing clinics.
Headline led the funding round, with participation from Village Global, TA Ventures, Operator Partners, and Correlation Ventures; additionally, Headline cofounder Mathias Schilling joins the board.
“We’ve taken a very deliberate and disciplined approach to fundraising,” founder and CEO John Zhao told , pointing out that all of Blossom’s funding rounds were oversubscribed, yet the company “could raise more but opts not to.” Capital, he added, “is both a tool and a risk.”
Zhao, who previously worked at two rapidly scaling startups—Athelas, now a multibillion-dollar firm, and online insurance marketplace EverQuote, which he helped grow to an IPO—views Blossom as an opportunity to build a “generational company” in mental health. “As long as there are people, we’ll need healthcare, and mental health is an increasingly significant part of each person’s overall well-being,” he stated.
He sees Blossom’s timing as a pushback against the idea that digital mental health was already addressed by the previous wave of teletherapy and telehealth platforms. Zhao described those platforms as “inadequate or absent” in the psychiatry realm.
Blossom promotes itself as an “all-in-one AI copilot” that both enhances psychiatrists’ clinical decisions and automates the back-office tasks that usually slow down in-network practices. This means shifting what Zhao calls historically “highly sporadic” care into an ongoing relationship fueled by AI agents that message patients between appointments, help identify warning signs, and prepare information for clinicians. He cited a postpartum depression example: instead of waiting a month for the next visit, Blossom conducts conversational check-ins via text about sleep and mood—“like texting a therapist”—rather than using static surveys. Typically, most patients on the platform are seen within 48 hours, often the same day.
Zhao is straightforward: AI in healthcare will only succeed if clinicians support it. “It begins with listening to clinicians—and not just listening, but involving them in developing all our AI products at every stage,” he said, noting that Blossom’s clinical director and “over 100 clinicians” test features before wider rollout.
He makes a clear distinction between clinical tools and administrative support, though. “These are ways we help clinicians treat patients more confidently, precisely, and effectively,” Zhao told . All other tasks—billing, scheduling, working with insurers and pharmacies—are managed by agents that replace what he calls the “team of people” once needed to run a clinic.
Blossom reports that its tools are already used by hundreds of clinicians caring for over 10,000 patients across several states, and it offers in-network coverage with major insurers and average copays of about $22. The company positions itself amid a landscape where roughly one in four U.S. adults have a mental health condition each year, and over 28 million adults with mental illness get no treatment whatsoever.
Zhao’s goal is to make Blossom the “top choice” in psychiatry, similar to JPMorgan Chase in retail banking, with specific plans to expand far beyond the nine states it currently serves in the near term, strengthen payer partnerships, and continue investing in applied AI research and development. “Previously, scaling was what caused healthcare companies to fail,” Zhao said. “Now we’ve reversed that model. The more we grow, the better we get at supporting our doctors and helping
This article is provided by a third-party content provider. SeaPRwire (https://www.seaprwire.com/) makes no warranties or representations regarding its content.
Category: Top News, Daily News
SeaPRwire provides global press release distribution services for companies and organizations, covering more than 6,500 media outlets, 86,000 editors and journalists, and over 3.5 million end-user desktop and mobile apps. SeaPRwire supports multilingual press release distribution in English, Japanese, German, Korean, French, Russian, Indonesian, Malay, Vietnamese, Chinese, and more.
